knowledge -WSS

knowledge

author：explore 2025-09-07 14:12:28 - browse：64

Medicare and money photo illustration. — Adobe

Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services. In a letter sent to the agency and shared with STAT, the group urged CMS to act on finalizing a pathway that would make reimbursement for breakthrough devices easier.

CMS has been working on implementing the pathway since 2021. A CMS spokesperson told STAT the agency is working “expeditiously” to finalize it. Scott Whitaker, CEO of AdvaMed, said the device industry is tired of waiting.

“I myself have begun to wonder if they’re really serious about doing this, or if they’re just saying they’re serious about doing it for political reasons or otherwise,” Whitaker told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： What to make of Biden’s latest efforts on cancer research

explore

WSS

PEPFAR is under serious threat — and so is global health

WATCH: Why do bright lights make us see spots?

WATCH: Why do bright lights make us see spots?

Will the IRA bring competition to the biologics market?

Medicare reduced heart disease by changing how it pays doctors

Food makers tried to stack nutrition panel with preferred experts

focus

knowledge

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

NIH confirmation hearing shows politicization of research

In Memoriam: Notable people who died in 2023

NIH confirmation hearing shows politicization of research

Cancer drug shortages should be causing more outrage

The EU Joint Clinical Assessment needs to live up to its promise

Wildfire smoke exposes gaps in outdoor worker protections

Hospital price transparency does save money, advocate argues

Medicare details structure of new drug price negotiation program

Walmart eyes Medicare Advantage provider ChenMed

knowledge

Popular nasal decongestant doesn't actually relieve congestion

Food makers tried to stack nutrition panel with preferred experts

Hospitals consider fixing cancer drug shortages on their own

FDA struggles to regulate food additives, sometimes for decades

New weight loss drugs vying to be the next Wegovy or Mounjaro

How medical schools plan to diversify without affirmative action

explore

hotspot

entertainment

Wikipedia